122 related articles for article (PubMed ID: 30832963)
1. Revascularization Rates and Associated Costs in Patients With Stable Ischemic Heart Disease Initiating Ranolazine Versus Traditional Antianginals as Add-on Therapy.
Meyer N; Tran O; Hartsfield C; Nguyen L; Kazi DS; Koch B
Am J Cardiol; 2019 May; 123(10):1602-1609. PubMed ID: 30832963
[TBL] [Abstract][Full Text] [Related]
2. Comparative Effectiveness of Ranolazine Versus Traditional Therapies in Chronic Stable Angina Pectoris and Concomitant Diabetes Mellitus and Impact on Health Care Resource Utilization and Cardiac Interventions.
Page RL; Ghushchyan V; Read RA; Hartsfield CL; Koch BR; Nair KV
Am J Cardiol; 2015 Nov; 116(9):1321-8. PubMed ID: 26358510
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris.
Bress AP; Dodson JA; King JB; Sauer BC; Reese T; Crook J; Radwanski P; Knippenberg K; Greene T; Nelson RE; Munger MA; Weintraub WS; LaFleur J
Am J Cardiol; 2018 Dec; 122(11):1809-1816. PubMed ID: 30292334
[TBL] [Abstract][Full Text] [Related]
4. Relative efficacy of antianginal drugs used as add-on therapy in patients with stable angina: A systematic review and meta-analysis.
Belsey J; Savelieva I; Mugelli A; Camm AJ
Eur J Prev Cardiol; 2015 Jul; 22(7):837-48. PubMed ID: 24776376
[TBL] [Abstract][Full Text] [Related]
5. Role of Ranolazine in Reducing Angina, Subsequent Revascularization, and Healthcare Expenditures in Stable Ischemic Heart Disease.
Rasalingam R; Boden WE
Am J Cardiol; 2019 May; 123(10):1729-1731. PubMed ID: 30922541
[No Abstract] [Full Text] [Related]
6. Do Clinical Outcomes and Quality of Life Differ by the Number of Antianginals for Stable Ischemic Heart Disease? Insights from the BARI 2D Trial.
Jamil Y; Park DY; Verde LM; Sherwood MW; Tehrani BN; Batchelor WB; Frampton J; Damluji AA; Nanna MG
Am J Cardiol; 2024 Mar; 214():66-76. PubMed ID: 38160927
[TBL] [Abstract][Full Text] [Related]
7. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
8. Influence of trimetazidine and ranolazine on endothelial function in patients with ischemic heart disease.
Rehberger-Likozar A; Šebeštjen M
Coron Artery Dis; 2015 Dec; 26(8):651-6. PubMed ID: 26049922
[TBL] [Abstract][Full Text] [Related]
9. Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.
Coleman CI; Freemantle N; Kohn CG
BMJ Open; 2015 Nov; 5(11):e008861. PubMed ID: 26546142
[TBL] [Abstract][Full Text] [Related]
10. Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.
Alexander KP; Weisz G; Prather K; James S; Mark DB; Anstrom KJ; Davidson-Ray L; Witkowski A; Mulkay AJ; Osmukhina A; Farzaneh-Far R; Ben-Yehuda O; Stone GW; Ohman EM
Circulation; 2016 Jan; 133(1):39-47. PubMed ID: 26555329
[TBL] [Abstract][Full Text] [Related]
11. Rate Control With Beta-blockers Versus Calcium Channel Blockers in the Emergency Setting: Predictors of Medication Class Choice and Associated Hospitalization.
Atzema CL; Austin PC
Acad Emerg Med; 2017 Nov; 24(11):1334-1348. PubMed ID: 28853232
[TBL] [Abstract][Full Text] [Related]
12. Costs and clinical outcomes associated with use of ranolazine for treatment of angina.
Phelps CE; Buysman EK; Gomez Rey G
Clin Ther; 2012 Jun; 34(6):1395-1407.e4. PubMed ID: 22608105
[TBL] [Abstract][Full Text] [Related]
13. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
Weisz G; Généreux P; Iñiguez A; Zurakowski A; Shechter M; Alexander KP; Dressler O; Osmukhina A; James S; Ohman EM; Ben-Yehuda O; Farzaneh-Far R; Stone GW;
Lancet; 2016 Jan; 387(10014):136-45. PubMed ID: 26474810
[TBL] [Abstract][Full Text] [Related]
14. Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris.
Ling H; Packard KA; Burns TL; Hilleman DE
Am J Cardiovasc Drugs; 2013 Dec; 13(6):407-12. PubMed ID: 23873327
[TBL] [Abstract][Full Text] [Related]
15. Medicare Accountable Care Organizations Are Not Associated With Reductions in the Use of Low-Value Coronary Revascularization.
Hollingsworth JM; Nallamothu BK; Yan P; Ward S; Lin S; Colla CH; Lewis VA; Ayanian JZ; Hollenbeck BK; Ryan AM
Circ Cardiovasc Qual Outcomes; 2018 Jun; 11(6):e004492. PubMed ID: 29903936
[TBL] [Abstract][Full Text] [Related]
16. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
[TBL] [Abstract][Full Text] [Related]
17. Effect of Ranolazine on Ischemic Myocardium IN Patients With Acute Cardiac Ischemia (RIMINI-Trial): A Randomized Controlled Pilot Trial.
Schwemer TF; Radziwolek L; Deutscher N; Diermann N; Sehner S; Blankenberg S; Friedrich FW
J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):62-69. PubMed ID: 29938533
[TBL] [Abstract][Full Text] [Related]
18. Ranolazine Reduces Angina in Women with Ischemic Heart Disease: Results of an Open-Label, Multicenter Trial.
Mehta PK; Sharma S; Minissian M; Harsch MR; Martinson M; Nyman JA; Shaw LJ; Bairey Merz CN; Wenger NK
J Womens Health (Larchmt); 2019 May; 28(5):573-582. PubMed ID: 30888919
[No Abstract] [Full Text] [Related]
19. Pharmacologic management of chronic stable angina.
Dixit D; Kimborowicz K
JAAPA; 2015 Jun; 28(6):. PubMed ID: 25989429
[TBL] [Abstract][Full Text] [Related]
20. Ranolazine: effects on ischemic heart.
Rognoni A; Barbieri L; Cavallino C; Bacchini S; Veia A; Degiovanni A; Rametta F; Nardi F; Lazzero M; Lupi A; Bongo AS
Recent Pat Cardiovasc Drug Discov; 2013 Dec; 8(3):197-203. PubMed ID: 23961914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
